SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddy’s launches generic dementia drug in US

23 Sep 2011 Evaluate

Dr Reddy’s Laboratories Ltd has launched Rivastigmine Tartrate capsules in the US market. The capsules are a bioequivalent generic version of Exelon capsules (of Novartis Pharmaceuticals Corporation) in the US market. They are indicated for the treatment of mild to moderate dementia of the Alzheimer’s type. The Exelon brand and generic rivastigmine tartrate had U.S. sales of approximately $92.6 million for the most recent twelve months ending June 2011.

Dr. Reddys Labs. Share Price

1353.55 25.20 (1.90%)
25-Jun-2026 11:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.75
Dr. Reddys Labs. 1353.55
Cipla 1441.50
Zydus Lifesciences 1101.50
Lupin 2376.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: